The VEC made the announcement Friday, after the expiration of temporary protections that the General Assembly had adopted to protect people who were overpaid benefits through no fault of their own ...

VEC activation secretes powerful inflammatory mediators and aggravates ... by expressing ANG-1, leading to TGF-β activation and ECM sedimentation, thus stabilizing the growing vascular bed. Downstream ...

Olvi-Vec showed a 71% disease control rate in phase 1b trial for advanced SCLC, with significant tumor reductions in some patients. The safety profile of Olvi-Vec was manageable, with mild to moderate ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...

A phase II trial found that T-VEC improved tumor resectability in 50% of patients, leading to early study discontinuation, with strong immune response activation and minimal side effects.

That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS signaling pathways work together to spur the spread of cancer ...

Several lines of evidence from the study of syndromic and sporadic forms of MVP point to the TGF-β pathway. The TGF-β pathway is involved in fundamental biology across multiple organ systems with ...

Patients with resectable melanoma who received T-VEC prior to surgery achieved better 5-year OS than those who underwent surgery alone. T-VEC-treated patients also achieved longer recurrence-free ...

“We have had tremendous progress,” said VEC Commissioner Carrie Roth. “There is still work to be done.” Roth documented the crush of claims for unemployment assistance as the pandemic ...